All News
Filter News
Found 808,896 articles
-
Nearly half a million dollars to fund a research chair to ensure food safety and quality
4/22/2021
In the food industry, the control of microbes, such as bacteria or viruses, often requires the addition of synthetic chemicals. Yet consumer demand for natural antimicrobial products is growing.
-
Wellcome Sanger Institute Adopts Genestack’s Omics Data Manager for Human Genetics Datasets
4/22/2021
Genestack Ltd. announced that its flagship multi-omics data catalog, curation and integrative search product, Omics Data Manager, has been licensed and implemented by a world-leading genomics research centre, the Wellcome Sanger Institute.
-
Owens & Minor will Report First Quarter Financial Results on Wednesday, May 5, 2021
4/22/2021
Owens & Minor, Inc. plans to release financial results for the first quarter of 2021 on Wednesday, May 5, 2021, before trading begins on the New York Stock Exchange.
-
RDIF and Minapharm agree to produce over 40 million doses of the Sputnik V vaccine in Egypt
4/22/2021
The Russian Direct Investment Fund, Egypt's Minapharm, the regional leader in recombinant DNA technology, and its Berlin-based subsidiary, ProBioGen AG, announce the agreement to produce over 40 million doses per year of the world's first registered vaccine against COVID-19, Sputnik V.
-
St. Jude EPIC Challenge blasts off, inspiring students to reach for the stars to help others
4/22/2021
Kids use their hearts, smarts for Inspiration4 St. Jude Science Fair; out-of-this-world prizes include opportunity to fill time capsule headed into space.
-
Immunovia reiterates its road to reimbursement for the IMMray™ PanCan-d test
4/22/2021
Immunovia is launching its IMMray™ PanCan-d test in the US as a Laboratory Developed Test in Q2 2021.
-
Quest Diagnostics Reports First Quarter 2021 Financial Results; Announces Plan for $1.5 Billion Accelerated Share Repurchase
4/22/2021
Quest Diagnostics Incorporated, the world's leading provider of diagnostic information services, announced financial results for the first quarter ended March 31, 2021.
-
Lipidor - update on the company's phase III clinical trial of drug candidate AKP02 for treatment of psoriasis
4/22/2021
Lipidor AB provides an update on the planned Phase III study of the company's drug candidate AKP02 for the treatment of psoriasis.
-
HMNC Brain Health Embarks on Next Phase of Growth with New Leadership Team
4/22/2021
HMNC Brain Health, a biotech company focused on the development of innovative and personalized treatments for depression and other neuropsychiatric disorders, enters a new phase of growth with a new leadership team.
-
Walgreens Boots Alliance Declares Quarterly Dividend - Apr 22, 2021
4/22/2021
Walgreens Boots Alliance, Inc. announced that its board of directors has declared a quarterly dividend of 46.75 cents per share, unchanged from the previous quarter and an increase of 2.2 percent from the year-ago quarter.
-
Anavo Therapeutics Launches with EUR 20 Million Seed Financing to Create Industry-Leading Pipeline of Allosteric Phosphatase Modulators
4/22/2021
Seed round was led by M Ventures and INKEF Capital, and co-led by Taiho Ventures and Bioqube Ventures
-
Poll: Oral Covid-19 Vaccine Pill Offers a Way to Overcome Vaccine Resistance of Millions of Americans
4/22/2021
Nearly 19 million Americans who will decline vaccines would get vaccinated if they had a pill option, Vaxart’s poll finds
-
Assertio Holdings, Inc. to Report First Quarter 2021 Financial Results After the Close of Markets on Thursday, May 6, 2021
4/22/2021
Assertio Holdings, Inc. announced that it will release first quarter 2021 financial results on Thursday, May 6, 2021, after the close of markets.
-
Endeavour Vision closes Endeavour Medtech Growth II LP at USD 375m to invest in transformative healthcare technologies
4/22/2021
The new fund will invest in disruptive technologies to streamline healthcare delivery and improve patient outcomes
-
Achieve Life Sciences, Inc. to Host Virtual Non-Deal Roadshow on Tuesday, April 27, 2021
4/22/2021
Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, announced it will be hosting a Virtual Non-Deal Roadshow on Tuesday, April 27, 2021, at 9:00AM EDT.
-
Galderma launches new Multichannel Medical Education platform: Inaugural webinar series on the impact of mask wearing on skin diseases
4/22/2021
Launching in May, an inaugural four-part webinar series Unmasking Facial Skin & Dermatoses will feature expert presentations from world-renowned dermatologists
-
DLH to Announce Second Quarter FY21 Financial Results
4/22/2021
DLH Holdings Corp., a leading healthcare and human services provider to the federal government, will release its financial results for the fiscal second quarter ended March 31, 2021 on May 5, 2021 after the market closes.
-
NervGen Pharma Announces Appointment of Pharma Veteran Dr. Daniel Mikol as Chief Medical Officer
4/22/2021
"We are thrilled to welcome Dan to NervGen," stated Paul Brennan, President & CEO of NervGen.
-
Jay S. Loeffler, MD Appointed to Co-Chair Medical/Technical Advisory Board
4/22/2021
Mevion Medical Systems announced that Jay S. Loeffler, MD, has been appointed Co-Chair of Mevion Medical Systems Medical/Technical Advisory Board.
-
Vitrolife AB: Interim report January-March 2021: Recovery and good profitability
4/22/2021
Sales amounted to SEK 379 (334) million, corresponding to an increase of 14 percent in SEK. Sales increased by 20 percent in local currency.